Search of molecules involved in vessel invasion of liver cancer and development of control methods.

2015 Fiscal Year Final Research Report

• Project/Area Number: 24592015
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Research Field: Digestive surgery
• Research Institution: Hyogo Medical University
• Principal Investigator: HIRANO TADAMICHI 兵庫医科大学, 医学部, 准教授 (90340968)
• Co-Investigator(Kenkyū-buntansha): IIMURO YUUJI 山梨大学, 総合研究部, 医学研究員 (30252018) ; HAI SEIKAN 兵庫医科大学, 医学部, 講師 (30423833) ; OHASHI KOICHIRO 兵庫医科大学, 医学部, 病院助手 (50573987) ; FUJIMOTO JIRO 兵庫医科大学, 医学部, 教授 (90199373) ; SUEOKA HIDEAKI 兵庫医科大学, 医学部, 助教 (20419831) ; NAKAMURA IKUO 兵庫医科大学, 医学部, 助教 (10625312)
• Project Period (FY): 2012-04-01 – 2016-03-31
• Keywords: 肝癌

Outline of Final Research Achievements

In the present study, we investigated the relation of chemokine for the vascular invasion of primary liver tumor. First, expression of CXCR2 is estimated by immunohistochemical staining in hepatocellular carcinoma (HCC) with vascular invasion using human specimens.
Expression of several chemokine was measured using ELISA in vitro. Accumulation of myeloid derived suppressor cells (MDSC) was examined immunohistochemically in human samples of HCC. As a result, CXCR2 expression was observed in tumor thrombi than original tumor. CXCL1, 5, 8 were markedly expressed in HCC cell line in vitro. Accumulation of MDSC was confirmed in tumor with vascular invasion compared with tumor without vascular invasion. Our results suggested that chemokine network have a crucial role in the vascular invasion oh HCC.

Free Research Field

肝癌分子治療